Enliven Therapeutics Inc. (ELVN)
19.98
0.12 (0.60%)
At close: Apr 03, 2025, 3:59 PM
20.52
2.72%
After-hours: Apr 03, 2025, 07:32 PM EDT
Enliven Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Buy
Price Target
39
Upside
95.20
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| HC Wainwright & Co. | Strong Buy | Maintains | 37 39 | 95.20% | Mar 21, 2025 | |
| BTIG | Buy | Initiates | 42 | 110.21% | Dec 13, 2024 | |
| Baird | Buy | Maintains | 32 40 | 100.20% | Nov 15, 2024 |
Trade Smarter, Not Harder
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.